• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

LifeCare Chiropractic

The Best Chiropractic Care in Mesa, Arizona

  • Home
  • About
    • Why Lifecare?
    • About Dr. Bogash
    • Team Members
  • Common Conditions
    • Wrist Pain/Carpal tunnel syndrome
    • Elbow Pain/Epicondylitis
    • Headaches
    • Knee Pain and Knee Injuries
    • Low Back Pain
    • Shoulder Pain and Rotator Cuff Problems
  • Additional Services
  • Testimonials
  • Blog
  • E-Books
  • Contact

cardiology

Angioplasty Sugery and After Stent Restenosis: Not Good News

October 6, 2012 by James Bogash

Interventional cardiology has made lifestyle changes obsolete. Angioplasty surgery can open clogged vessels and put a stent in. But what about life after stent?

So your cardiologist has told you that you need to have a procedure done. They think the blood vessels going into your heart are blocked, and they want to slice you open near the groin, stick a probe up to your heart and check things out.

If they find a blockage, they’re going to open up the vessel and prop it up with a stent to keep it open.  Here’s where the big decision comes in:  Bare metal stent (BMS) or drug-eluting stent (DES)??

Let’s cover the choices.

Worst scenario that everyone wants to avoid is the full blown, chest cracking coronary artery bypass graft (CABG).  This is the end of the line as far as cardiac procedures (not counting death, which, arguably, is NOT a cardiac procedure….).

When percutaneous procedures began (this is the catheter that is inserted near the groin), they were initially done with just a balloon. The blocked artery was blown up and left alone. The problem was with restenosis, the term describing the re-closure of the artery. This was very common (upwards of 90% of cases) and sometimes let to emergency CABG.

Someone then came up with the idea of propping open the balloon-expanded artery with a piece of bare metal, essentially creating a tunnel. Working better than the balloon alone, but the restenosis rate was still a problem.

THEN, someone thought of coating the stent in an immunosuppresive drug (initially Sirolimus) to kill off the cells trying to grow back into the stent.

At this point, there was much argument about whether the bare metal stents or the drug eluting stents had better outcomes. The research was pointing towards DES being a better long term option. (Research, however, has shown that levels of inflammation are a determining factor here)

So, back to the decision you need to make before your groin region gets sliced and a tube inserted remotely into your vital organ…

Bare metal stent or drug eluting.  What if it REALLY doesn’t matter?

Sure, the short term outcomes seem to favor DES. But who wants to live only another year or two?

This particular study looked at longer, more realistic timeframes.

They also looked at the characteristics of the plaque forming inside of the stent. Lipid containing plaques are more likely to rupture, throwing off a clot and triggering a heart attack.  Not good.

Here’s what they found:

  1. 138 stents were looked at.
  2. In the early phase, under 9 months, the DES had much more fatty plaquing.
  3. In the intermediate phase, between 9 and 48 months the DES still had much fattier plaques.
  4. In the delayed phase, after 48 months the plaquing had evened out, and it was composed of the fattier, more dangerous, material.

So, in the long run, it doesn’t really matter what type of stent you or your cardiologist chooses, after 4 years the news is not good. While this study included a relatively small number of procedures, it seems to fit with what we know about the long term outcomes following this type of procedure. In non-emergent situations, we have known for years that percutaneous coronary intervention does not save lives over conservative care (which means drugs, which is a pretty poor standard to compare PCI to in the first place).

We have spent millions of research dollars to try to find out whether drug eluting or bare metal stents are the best option, and yet neither makes much of a difference in the long run. How much better could that money have been spent on educating the general public about something like refined carbohydrates?

If you happen to be in the population that has had a stent put in, never fear. The fact that this procedure, in someone who was not in the middle of an acute heart attack, has been shown in research studies to be worthless does not mean that there is nothing you can do.

Lifestyle changes will always prevail and have been shown again and again and again to lower the risk of cardiac events and death. Heck–even just adding in dark chocolate can greatly lower your odds of having a second heart attack.

So, if you have suffered a heart attack, what changes have you made to make sure it’s your last?

Filed Under: Heart Disease Tagged With: angioplasty, angioplasty surgery, bare metal stents, cardiology, coronary stent, drug eluting stent, drug eluting stents, eluting stent, interventional cardiology, metal stent, percutaneous coronary intervention, restenosis, stent, stent restenosis

EARLY EFFECTS OF ENDOTHELIAL FUNCTION – (05-29-06)

August 5, 2012 by James Bogash

Early Effects on Endothelial Function of Atorvastatin 40 mg Twice Daily and its withdrawal

So, giving high dosages of this statin drug was beneficial for only a subset of patients, and when they were taken off the drug, the unhealthy response of their blood vessels returned within 3 days. The irony is that this is under “preventative cardiology” section in this journal.

Should be under the “studies to support long term pharmaceutical use to boost profits” section. Mainstream medicine still views “prevention” as the use of drugs to impact a condition before a more serious event occurs. So long as they maintain this viewpoint, they will never understand wellness and what it takes to help a patient get truly healthy. .

Read entire article here

Filed Under: Drug Research, Heart Disease Tagged With: Atorvastatin, cardiology, Endothelial, statin drug

COMPARISON OF LONG TERM OUTCOMES AMONG PATIENTS – (08-28-06)

July 12, 2012 by James Bogash

Comparison of Long-Term (Seven Year) Outcomes Among Patients Undergoing Percutaneous Coronary Revascularization With Versus Without Stenting.

This is one I can’t hammer on long enough. We have created a huge and profitable subsection of cardiology that, quite frankly, does nothing to change long term outcomes in patients. Cardiologists are getting rich on PCI procedures that, from several studies now, have failed to show a long term benefit. I could not begin to calculate the costs associated with these procedures collectively, but I can guarantee that lifestyle changes would be a little cheaper.

Read entire article here

Filed Under: Heart Disease Tagged With: cardiology, PCI, Percutaneous Coronary Revascularization, stenting

RISK IN A CARDIAC EVENT FOLLOWING BYPASS SURGERY – (10-02-06)

June 17, 2012 by James Bogash

Usefulness of Preoperative C-Reactive Protein and Soluble Intercellular Adhesion Molecule-1 Level for Predicting Future Cardiovascular Events After Coronary Artery Bypass Grafting.

The routine analysis of CRP levels is still resisted by the mainstream cardiologists. However, in this study, elevated CRP levels produced a 3.9 times risk in a cardiac event following bypass surgery. Cardiology in this country still does not entertain the idea that lifestyle changes (those that would lower CRP levels) are an integral part of management of the cardiology patient.

Maybe that’s why CVD deaths still rank #1 despite enormous amounts of research suggesting that in excess of 90% of these deaths are preventable with lifestyle changes.

Read entire article here

Filed Under: Heart Disease Tagged With: C-reactive protein, cardiology, Coronary Artery Bypass, CRP levels

Primary Sidebar

Patient Quick Guide

Schedule An Appointment
Contact Our Office
Download Patient Forms

Categories

Chiropractic Mesa Arizona

Arthritis Chiropractor Mesa AZ
Graston Technique Mesa AZ
Back Pain Chiropractor Mesa AZ
Back Pain Doctor Mesa AZ
Wrist Pain Chiropractor Mesa AZ
Rotator Cuff Chiropractor Mesa AZ
Shoulder Pain Chiropractor Mesa AZ
Knee Pain chiropractor Mesa AZ
Manipulation Under Anesthesia In Mesa AZ
Headache Chiropractor Mesa AZ
Chiropractic Mesa AZ
Stem Cell Therapy Mesa AZ
Regenerative Medicine Mesa AZ
Massage Therapist Mesa AZ
Shoulder Pain Doctor Mesa AZ
PRP Therapy Mesa AZ
Chiropractic Mesa AZ
Who Is The Top Chiropractor In Mesa AZ?
Knee Injury Doctor Mesa AZ?

Footer

Resources

Site Map
Disclosure
Additional Resources

Best Massage Therapist Mesa AZ
Arthritis Doctor Mesa AZ
Chiropractic Mesa AZ
Back Pain Doctor Mesa AZ
Rotator Cuff Doctor Mesa AZ
Chiropractor Mesa AZ
Massage Therapist Mesa AZ
PRP Therapy Mesa AZ
Knee Pain Doctor Mesa AZ
Stem Cell Therapy Mesa AZ
Headache Doctor Mesa AZ
Shoulder Pain Doctor Mesa AZ

Office

Lifecare Chiropractic
1830 S. Alma School Rd, Ste 135
Mesa, AZ 85210
(480)-839-2273
Also Serving Tempe, AZ

Get Directions

  • Home
  • About
  • Common Conditions
  • Additional Services
  • Testimonials
  • Blog
  • E-Books
  • Contact

Copyright © 2026 · LifeCare Chiropractic · All Rights Reserved.